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Pitx2, a homeodomain transcription factor, is essential for normal development of pituitary, eyes, heart, and teeth. In the
developing mouse brain, Pitx2 (Rieg, Ptx2, Otlx2, Brx1) mRNA is expressed in discrete regions of the diencephalon,
mesencephalon, and rhombencephalon. While prior reports have provided an overview of the temporal and regional
specificity of Pitx2 mRNA expression in the brain, the precise cell types that express PITX2 are not known. In this study,
we analyzed Pitx2 mRNA and PITX2 protein expression in individual cells of the developing e10.5–e14.5 mouse CNS using
multiple markers of cellular proliferation and differentiation. We identified Pitx2 expression in nestin-positive neural
progenitors and in postmitotic, developing neurons. In the diencephalon, PITX2 is expressed in neurons of the zona limitans
intrathalamica and mammillary region and in -aminobutyric acid (GABA)-producing neurons of the zona incerta. In the
mesencephalon, PITX2-labeled nuclei also appear in differentiated neurons, some of which are GABAergic and destined to
occupy superior colliculus. Our results suggest that PITX2 expression in postmitotic neurons may contribute to
development of GABAergic and other differentiated neuronal phenotypes. © 2002 Elsevier Science (USA)
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Pitx2 belongs to a family of transcription factors (Pitx1,
Pitx2, and Pitx3) named for their homology and expression
of Pitx1 and Pitx2 in the pituitary gland. Pitx2 and Pitx3 are
expressed in the neuroepithelium, whereas Pitx1 expres-
sion in the head is limited to the pituitary. Pitx3 transacti-
vates tyrosine hydroxylase transcription and is thought to
participate in specification of mesencephalic dopaminergic
neurons (Lebel et al., 2001; Semina et al., 1997; Smidt et al.,
1997). Pitx2 mRNA is expressed in the zona limitans
intrathalamica (zli), in the e8.5 embryonic mouse head
mesenchyme, and at later time points in the pituitary,
diencephalon, mesencephalon, first rhombomere, and ven-
tral spinal cord (Kitamura et al., 1997; Lindberg et al., 1998;
Mucchielli et al., 1996). In the postnatal rodent brain, Pitx2
mRNA is expressed in multiple brain nuclei, including the
subthalamic nucleus, posterior nucleus of the hypothala-
184mus, red nucleus, and reticular thalamic nucleus (Lindberg
et al., 1998; Mucchielli et al., 1996; Smidt et al., 1997,
2000). While the overall anatomical distribution of Pitx2
has been described, the characteristics of individual cells
are unknown. In this study, we asked whether PITX2 is
expressed in proliferative or postmitotic cells, and whether
PITX2-positive cells could be characterized on the basis of
expression of cell-specific phenotypic markers.
In humans, PITX2 haploinsufficiency is one cause of
Rieger syndrome, defined by ocular anterior segment dys-
genesis, umbilical abnormalities, and tooth dysgenesis
(Semina et al., 1996). Rare individuals with Rieger syn-
drome features also have mental retardation or severe
developmental delay (De Hauwere et al., 1973; Summitt et
al., 1971). Mice deficient in Pitx2 exhibit defects in eyes,
thoracic and abdominal viscera, and craniofacial regions
similar to some of the anomalies in humans with reduced
PITX2 function (Gage et al., 1999; Kitamura et al., 1999; Lin
et al., 1999; Liu et al., 2001). There is excellent correspon-
dence between areas of high Pitx2 mRNA expression devel-
opmentally and regions affected in knockout mice. Expres-
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sion levels in the zli, ventral diencephalon, and
mesencephalon are similar to those in the eye, heart, and
pituitary, supporting the idea that Pitx2 is important for
normal CNS development. No histological abnormalities
have been reported in Pitx2-deficient mice, and early lethal-
ity precludes analysis of Pitx2 function in late gestation and
adulthood.
Here, we report the fate of Pitx2-expressing cells in the
developing mouse CNS. We examined the association of
Pitx2 with GABAergic neurons because PITX2 transacti-
vates transcription of Gad1 (glutamic acid decarboxylase),
the gene encoding the 67-kDa isoform of the rate-limiting
enzyme for GABA synthesis (GAD67; for review, see Sog-
homonian and Martin, 1998). Interestingly, a Pitx2 homo-
logue, unc-30, is essential for GABAergic neuronal differen-
tiation in Caenorhabditis elegans (Westmoreland et al.,
2001). We demonstrate that postmitotic PITX2 neurons
express markers specific for the developing GABAergic
lineage. Our results implicate a role for PITX2 in differen-
tiation of GABAergic and other neurons destined to com-
prise specific CNS regions.
MATERIALS AND METHODS
Mice and Tissue Preparation
All procedures involving mice were approved by The University
of Michigan Committee on the Use and Care of Animals (UCUCA).
Timed pregnant 6-week-old CD-1 mice were obtained from Charles
River Laboratories (Wilmington, MA). Hysterectomy was per-
formed after cervical dislocation, and embryos were harvested at
e10.5–e14.5 days gestation (with day 0.5 designated as the morning
the plug was identified). Pregnant mice were injected intraperito-
neally with 5-bromo-2deoxyuridine (BrdU; Sigma, St. Louis, MO)
at 0.1 g/g body weight 4 h prior to harvest. Embryos were harvested
in PBS, fixed in 4% paraformaldehyde/PBS, pH 7.2, for 1–4 h, then
dehydrated in a series of increasing ethanol concentrations to 70%
ethanol and stored at 4°C. Embryos were subsequently dehydrated
in increasing concentrations of ethanol to 100%, then rinsed in
methylsalicylate and embedded in paraffin. Serial 7-m sections
were cut with a microtome and mounted on baked Superfrost plus
slides (Fisher, Pittsburgh, PA).
In Situ Hybridization
In situ hybridization (ISH) was performed on mounted embryo
sections by using digoxigenin-labeled riboprobes as previously
described (Brinkmeier et al., 1998). Pitx2 antisense and control
sense cRNA probes corresponding to the 3 end of Pitx2 were
constructed (Suh et al., 2002), and ISH was performed at 57°C
annealing temperature. The Pitx2 cDNA corresponds to 410 bp of
3 coding sequence and 280 bp of 3 UTR and identifies all three
Pitx2 isoforms (Hoonkyo Suh, personal communication). Gad1
cDNA was generously provided by Brian Condie (Maddox and
Condie, 2001).
Immunohistochemistry
For immunohistochemistry, endogenous peroxidase activity was
blocked with 3% H2O2 for 20 min, and nuclear epitopes were
exposed by boiling in 0.01 M citrate for 10 min. All subsequent
washes were performed in PBS with 0.5% Tween 20. PITX2
immunoreactivity (PITX2-IR) was detected by incubation with a
FIG. 1. Pitx2 mRNA in the e10.5 mouse embryo. Line drawing in
(A) shows the plane of section used for (C). (B) The plane of sections
used for (D–F). In (B), “A” is anterior and “P” is posterior. Pitx2
mRNA is present in the ventral diencephalon (arrows, di), dorsal
mesencephalon (arrowheads, mes), Rathke’s pouch (RP), and oral
ectoderm (Oect). Scale bars are 100 m in (C–F).
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FIG. 2. PITX2-immunoreactivity in postmitotic cells at e10.5. Immunolabeling of PITX2 (TRITC, red nuclei) and BrdU or H3 (FITC, green
nuclei) in representative sections from e10.5 embryos exposed to BrdU 4 h prior to harvest. Boxed areas in (A), (C), (E), and (G) are enlarged
in (B), (D), (F), and (H), respectively. The line drawing to the left of (A) shows the plane of section for (A, B), (C, D), (E, F), and (G, H). PITX2-IR
is present in the mantle zone of the mesencephalon (mes in A, C, E, G) and throughout the neuroepithelium of the ventral diencephalon.
In the mesencephalon, PITX2-IR nuclei do not label with either marker of proliferation marker, BrdU or H3 (arrows in A, C, E, G). In the
diencephalon (di), PITX2-IR forms a gradient of intensity with the lightest label near the ventricular zone (VZ) and the darkest label in the
mantle zone (MZ). Scale bars are 100 m in (A), (C), (E), and (G), and 25 m in (B), (D), (F), and (H).
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polyclonal rabbit anti-PITX2 antibody (kindly provided by Tord
Hjalt; Hjalt et al., 2000) diluted 1:400 overnight at 4°C followed by
tyramide signal amplification fluorescence with TRITC (NEN Life
Science Products; Boston). Double labeling was performed with
anti-PITX2 and rabbit anti--amino butyric acid (GABA; diluted
1:100; Sigma, St. Louis, MO; catalog no. A2052), rabbit anti-
tyrosine hydroxylase (diluted 1:100; Pelfreez, Rogers, AR), rat
anti-BrdU (diluted 1:100; Harlan Sera-Lab Limited, Loughborough,
England), rabbit anti-phosphohistone H3 (diluted 1:200; Upstate
Biotechnology, Lake Placid, NY), mouse anti--tubulin III (TUJ1;
diluted 1:1000; Covance, Richmond, CA), mouse anti-nestin (di-
luted 1:100; Developmental Studies Hybridoma Bank, Department
of Biological Sciences, University of Iowa, Iowa City, IA), mouse
anti-vimentin (diluted 1:100; Sigma), mouse anti-MAP2 (diluted 1:
200; Chemicon International Inc., Temecula, CA), mouse anti-
GFAP (diluted 1:100; Sigma), or mouse anti-O4 (diluted 1:100;
Chemicon International Inc.), followed by incubation with FITC-
conjugated secondary antibodies from the appropriate species.
Slides were counterstained with 4,6-diamidino-2-phenylindole,
dihydrochloride (DAPI), FluoroPure grade (167 ng/ml; Molecular
Probes, Eugene, OR). Sections were photographed by single channel
(FITC or TRITC) fluorescence microscopy on a Leica inverted
DMIRB or upright DMRB microscope and processed for dual
channel imaging by using Adobe Photoshop software v5.5 or v6.0
(San Jose, CA). Confocal images were obtained by using a Zeiss-
Axiovert 100M microscope.
RESULTS
We focus on e10.5–e14.5 of gestation since this is a period
of intense cell proliferation, neurogenesis (Altman and
Bayer, 1978), and Pitx2 mRNA expression, and precedes the
demise of Pitx2 homozygous null embryos. The embryonic
mouse CNS is a dynamic structure with constantly chang-
FIG. 3. PITX2 immunoreactivity in postmitotic cells of the e12.5 mouse embryo. Immunolabeling of PITX2 (TRITC, red nuclei) and BrdU
or H3 (FITC, green nuclei) in sagittal sections of an e12.5 embryo exposed to BrdU for 4 h in utero. The inset in (B) shows the plane of section
for (A, D), (B, E), and (C, F, G). (G) PITX2-IR and H3-IR done on a section adjacent to that from (C, F). PITX2-IR is present in the alar and
basal mesencephalon (ames, bmes, mes), zona limitans intrathalamica (zli), zona incerta/retromammillary region (zi/rmr), and first
rhombomere (R1). Scattered PITX2-IR nuclei extend from the ventral diencephalon dorsally, toward the pretectum (pt) and mesencephalon
or future superior colliculus (arrows in A, D). These cells form a continuous stream between ventral diencephalon and dorsal
mesencephalon. PITX2-IR in most regions is limited to the differentiating zone, whereas in the medial ventral diencephalon, some faintly
labeled, PITX2-positive nuclei reside near the ventricular surface (arrows in F, G). Other abbreviations: Aq, cerebral aqueduct; cf, cephalic
flexure. Scale bars are 25 m in (A–C), 400 m in (D), 100 m in (E, F, and G).
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FIG. 4. PITX2 immunoreactivity in developing e10.5 CNS neurons. Double-labeling for PITX2 (TRITC, red nuclei) and neuron-specific -tubulin
(TUJ1) or MAP2 (FITC, green cytoplasmic label) on sections of an e10.5 embryo. Line drawings in (A) and (G) illustrate the plane of section for (A–F) and
(G–M), respectively. (L) A confocal image. Areas from sections in the leftmost column (A, D, G, and J) are successively enlarged in panels to their right,
as indicated in the boxes. In the mesencephalon (mes), PITX2 label coincides with neuron-specific TUJ1 label in some cells (solid arrows in C, I, and
L), whereas other PITX2-labeled cells are negative for TUJ1 (open arrow in C). Some TUJ1-positive cells in the mesencephalon are negative for PITX2
label (open arrow in L). MAP2 colocalizes with most (solid arrow, M) PITX2-positive nuclei, but not all (open arrow, M) in a region of the basal
mesencephalon differentiating zone similar to (L). In the diencephalon (di), PITX2 label is present in TUJ1-positive cells throughout the neuroepithelium
(arrows in F) but is most intense near the pial surface. Other abbreviations: cf, cephalic flexure; Aq, cerebral aqueduct; IIIv, third ventricle. Scale bars are
200 m in (A), (D), (G), and (J), 100 m in (B), (E), and (H), 50 m in (C), (F), (I), and (K), and 25 m in (L) and (M).
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ing anatomical landmarks (Puelles, 2001). In this study, our
anatomical descriptions refer to the longitudinal axis of the
developing CNS, with the anterior-most aspect of the
embryo occupying the region of the developing eye, and the
posterior-most aspect extending toward the spinal cord. We
recognize that, as the embryo undergoes its sharp cephalic
flexure, the longitudinal axis bends and makes rostral/
caudal, dorsal/ventral, and anterior/posterior dimensions
confusing even to the experienced reader. We use dorsal and
ventral in reference to alar and basal aspects of the neural
tube, respectively, and rostral or caudal to describe anterior
or posterior directions along the neuraxis, irrespective of
whole animal coordinates. Thus, the same plane of section
that passes tangentially through the neural tube at one
point may pass transversely at another (e.g., see plane E in
Fig. 2). Sagittal sections are those taken along the longitu-
dinal axis of the neural tube. To minimize confusion, we
have provided line drawings with the figures to indicate the
plane of section being discussed.
Pitx2 mRNA in the Developing Mouse CNS
We performed a detailed analysis of Pitx2 mRNA expres-
sion at e10.5–e14.5 in the mouse CNS. At e10.5, Pitx2
mRNA is present in the differentiating or mantle zone of
the ventral diencephalon and the mesencephalon (Fig. 1). In
all slides examined, Pitx2 mRNA expression was bilateral
and symmetric, with no apparent differences between left
and right sides. Sense Pitx2 control cRNA probes showed
no hybridization with target sequences. Earlier studies
reported Pitx2 mRNA expression in head mesenchyme as
early as e8.5, and in the e10.5 mesencephalon by whole-
mount analysis (Mucchielli et al., 1996). Our studies con-
firm the Pitx2 mesencephalic expression and also demon-
strate Pitx2 expression in the e10.5 diencephalon. The Pitx2
mRNA signal we identified appears limited to the mantle or
differentiating zone of both the diencephalon and mesen-
cephalon. We also detected Pitx2 mRNA expression in the
e12.5–e14.5 CNS in a pattern consistent with previous
reports (data not shown) (Kitamura et al., 1997; Mucchielli
et al., 1996).
Pitx2 Expression in Postmitotic CNS Cells
Pitx2 mRNA expression in the neuroepithelium at e10.5–
e14.5, a period of intense neurogenesis and proliferation,
suggested a role for PITX2 in fate determination or differ-
entiation of neural progenitor cells. To determine whether
PITX2-positive CNS cells are postmitotic, we performed
immunohistochemistry on e10.5–e12.5 mouse embryos,
using antisera against PITX2 and two different markers of
cellular proliferation, BrdU, and anti-phosphohistone H3.
BrdU-positive nuclei reside in S-phase cells exposed to BrdU
during the 4-h exposure period. Cell cycle parameters for
the e13–e15 developing murine cerebral wall are reported as
6–7 h for S-phase, 1 h for G2 phase, 1 h for M-phase, and 4–7
h for G1 phase (Misson et al., 1988). If similar cell cycle
parameters hold true for the e10.5 diencephalon, then a 4-h
BrdU pulse is likely to label roughly 60–70% of the prolif-
erating cells, some of which would still be in S-phase at the
time of sacrifice, while others would have advanced to G2
and M, but very few to G1. In contrast, labeling with
anti-phosphohistone H3 identifies only M-phase nuclei
(Ajiro et al., 1996; Mahadevan et al., 1991). Use of both
markers can reveal progressive changes in cellular prolifera-
tion and migration.
PITX2 antisera, when used in combination with tyramide
signal amplification and fluorescence imaging, revealed
FIG. 5. PITX2- and TUJ1-positive neurons in the e12.5 CNS. A
parasagittal section of an e12.5 mouse embryo double-labeled for
PITX2 (TRITC, red) and TUJ1 (FITC, green). The insert to the left
of (A) is a line drawing showing the plane of section. (B) is enlarged
from the boxed area in (A). PITX2 nuclei reside in TUJ1-positive
neurons of the mesencephalon (mes), pretectum (pt), zona incerta/
retromammillary region (zi/rmr), mammillary region (mr), and
zona limitans (zli, arrows in B). Other abbreviations: cf, cephalic
flexure. Scale bars are 400 m in (A) and 25 m in (B).
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vividly labeled cellular nuclei (Fig. 2). In all experiments,
PITX2 label was restricted to the nucleus when compared
with DAPI nuclear-specific signal (data not shown), indicat-
ing lack of cytoplasmic staining. PITX2-immunoreactivity
(PITX2-IR) was distributed throughout the nucleus in a
nonhomogeneous fashion, forming a speckled appearance.
This speckling may reflect an underlying nuclear sublocal-
ization for PITX2 with some functional significance, as
reported for Runx transcription factors and other nuclear
localized proteins (Stein et al., 2000; Zaidi et al., 2002).
At e10.5, PITX2-IR is present in cellular nuclei of the
mesencephalon and ventral diencephalon (Figs. 2A–2H).
Sites of PITX2 protein expression confirm Pitx2 mRNA
expression at e10.5 and also reveal weaker PITX2 signal in
the proliferative and marginal zones (compare Figs. 1 and 2).
In the mesencephalon, PITX2-IR nuclei occupy the mar-
ginal and mantle zones and are negative for BrdU label
(arrows in Figs. 2A and 2E). In the ventral diencephalon,
PITX2-IR nuclei span the width of the neuroepithelium,
with a gradient of decreasing label intensity from the
FIG. 6. PITX2 immunoreactivity in e10.5 GABAergic neurons. Immunolabeling of PITX2 (TRITC, orange labeled nuclei) and GABA
(FITC, green) in e10.5 embryonic sections. The inset in (A) is a line drawing showing the plane of section for (A–D). Box in (A) is enlarged
in (C), and (C) is enlarged in (D). PITX2-IR and GABA-IR colocalize in the mantle zone of the ventral mesencephalon (mes in A–C, and arrow
in D). A bilateral, symmetric patch of GABA immunoreactivity in the ventral diencephalon (di) creates a sharp border (arrows in A, B) with
PITX2-IR cells. (E) is a midsagittal section showing PITX2-positive, GABA-expressing cells in the mesencephalon (white outlined arrow in
E) but not in the diencephalon (solid white arrow in E). Other abbreviations: Aq, cerebral aqueduct; IIIv, third ventricle; cf, cephalic flexure.
Scale bars are 100 m in (A), (B), and (E), 25 m in (C), and 6.25 m in (D).
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FIG. 7. PITX2 and GABA immunoreactivity in the e12.5 mouse CNS. PITX2 (TRITC, red nuclei) and GABA (FITC, green) label in a
representative parasagittal e12.5 section. The inset in (A) is a line drawing of the plane of section. Boxes in (A) are enlarged in (B–E) as
indicated. Boxes C and D are confocal images. Areas of notable overlap between PITX2 and GABA immunoreactivity are the alar and ventral
mesencephalon (ames, bmes in A, mes in B), zona limitans (zli, long arrows in A, C), zona incerta/retromammillary region (zi/rmr in D),
and first rhombomere (R1 in A, E). GABA-positive, PITX2-labeled nuclei also occupy the pretectum (arrows, pt). In contrast, the
PITX2-positive mammillary region (mr) is negative for GABA immunoreactivity. Other abbreviations: Aq, cerebral aqueduct; cf, cephalic
flexure. Scale bars are 200 m in (A), 25 m in (B) and (D), and 16.7 m in (C) and (E).
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mantle zone to the ventricular zone (Figs. 2B, 2D, 2F, and
2H). This gradient of decreasing intensity across the neuro-
epithelium represents less PITX2 label within each cell,
based on counterstaining with DAPI (data not shown). In
the medial ventral diencephalon, there is scant PITX2 label
in cells that line the ventricle, and in double-labeling
experiments with BrdU or H3, these nuclei stain light green
rather than yellow (Figs. 2B, 2D, 2F, and 2H), indicating
weak to minimal colocalization between PITX2-TRITC and
BrdU-FITC or H3-FITC signals. Our results demonstrate
that PITX2 is expressed primarily in postmitotic cells of the
e10.5 mesencephalon and diencephalon.
In the e12.5 neuroepithelium, PITX2-IR is concentrated
in the zli, zona incerta/retromammillary region, mammill-
ary region, pretectum, mesencephalon, and first rhom-
bomere. In each of these areas, PITX2 label is distinct from
BrdU or H3 immunoreactivity, indicating PITX2 expression
in quiescent cells (Figs. 3A–3G). This is strikingly visible at
the zli, which forms the border between future dorsal and
ventral thalami (Fig. 3D). In the zli, BrdU-labeled nuclei
occupy regions adjacent to and flanking PITX2-positive
cells, further indicating that PITX2 cells in the zli are
postmitotic. In the ventral diencephalon, there is still scant
PITX2 label in cells lining the ventricle, and in double-
labeling experiments with BrdU or H3, these nuclei appear
light green (arrows in Figs. 3F and 3G) similar to their e10.5
counterparts (Figs. 2F and 2H), indicating that PITX2 is
preferentially expressed in postmitotic cells. PITX2-
positive cells in the e12.5 neuroepithelium are presumed to
have embarked on their migration toward the mantle zone
as neurogenesis ensues.
Pitx2 Expression in e10.5–e14.5 CNS Neurons
Based on our observations of PITX2 expression in post-
mitotic neuroepithelial cells of the diencephalon, mesen-
cephalon, and rhombencephalon during e10.5–e12.5, we
hypothesized that PITX2 may be important for neurogen-
esis or in specifying neuronal fate. At e10.5–e14.5, the
murine CNS neuroepithelium comprises of mitotically
active neural progenitors and postmitotic developing neu-
rons. To test whether postmitotic, developing neurons
express PITX2, we performed double-label immunohisto-
chemistry with anti-PITX2 and a monoclonal antibody
against neuron-specific class III -tubulin (TUJ1) (Moody et
al., 1989). At e10.5, TUJ1-positive cytoplasmic label iden-
tifies mesencephalic neurons that occupy the mantle zone
(green label in Fig. 4C). By confocal imaging of double-
labeled cells in intact tissue sections, PITX2-IR nuclei
appear to be present in TUJ1-labeled cells of the mesen-
cephalon (Figs. 4A–4C and 4G–4L) and diencephalon (Figs.
4D–4F). Most PITX2-positive nuclei reside in TUJ1-positive
cells; however, the labeling pattern is not one-to-one. Some
PITX2-IR nuclei occupy regions of the neuroepithelium
void of TUJ1 label (open arrow in Fig. 4C), and some
TUJ1-labeled neurons are not labeled for PITX2 (open arrow
in Fig. 4L) but label positively for the nuclear marker DAPI
(data not shown). In the mesencephalon, PITX2-positive,
TUJ1-negative cells occupy the marginal zone, whereas
cells expressing both PITX2 and TUJ1 occupy the mantle
zone (solid arrows in Figs. 4C, 4I, and 4L), suggesting that
PITX2-positive cells express TUJ1 upon arrival in the
mantle zone. In the ventral diencephalon, cells label posi-
tively for both TUJ1 and PITX2 throughout the neuroepi-
thelium (arrows in Fig. 4F), with more intense colocaliza-
tion in the mantle zone, consistent with PITX2 expression
in differentiating neurons. In the e10.5 CNS, PITX2 is also
expressed in cells labeled positively for microtubule-
associated protein 2 (MAP2), a marker of differentiated
neurons (Fig. 4M).
As development proceeds from e10.5 to e12.5, the distri-
FIG. 8. In situ hybridization of Pitx2 and Gad1 mRNA at e12.5.
Parasagittal, adjacent sections through the e12.5 CNS were labeled
for Pitx2 (A) or Gad1 (B). In (A), Pitx2 mRNA is expressed in the
zona limitans intrathalamica (zli), zona incerta/retromammillary
region (zi/rmr), mesencephalon (mes), pretectum (pt), and Rathke’s
pouch (RP). In (B), Gad1 mRNA is expressed in the dorsal thalamus
(dt) and ventral thalamus (vt) adjacent to but excluding the zli.
Scale bars are 1 mm.
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bution of TUJ1-IR becomes more widespread throughout
the neuroepithelium (Fig. 5A), and there is a dramatic
expansion in the number of cells as revealed by DAPI (data
not shown; see Fig. 3, BrdU-labeled e12.5 nuclei). This
expansion in neuronal outgrowth is accompanied by expan-
sion of the PITX2-positive cell population in both the
diencephalon and mesencephalon (Figs. 3 and 5). At e12.5,
PITX2 nuclei occupy neurons of the zli (Fig. 5A; arrows in
Fig. 5B), zona incerta/retromammillary region, mammillary
region, pretectum, and mesencephalon (Fig. 5A), and are not
seen in areas where TUJ1 is absent, indicative of PITX2-
expressing cells adopting a primarily neuronal phenotype.
To determine whether PITX2-positive neurons are
GABAergic, we performed double-label immunohistochem-
istry with antibodies against PITX2 and GABA. We identi-
fied a subset of cells in the e10.5 ventral mesencephalon
that by confocal microscopy appear to label positively for
nuclear PITX2-IR and cytoplasmic GABA-IR (Figs. 6A–6D).
In this region, PITX2-positive nuclei appear more sparsely
distributed than in other regions of the mesencephalic
neuroepithelium (Figs. 6A–6C). TUJ1-positive neurons and
Gad1 mRNA were also detected in a similar region of the
ventral mesencephalon on adjacent sections (data not
shown), indicating that PITX2-positive, GABAergic cells in
the mesencephalon are neurons whose GABA neurotrans-
mitter production derives from Gad1. In contrast, GABA-IR
and PITX2-IR are mutually exclusive in the ventral dien-
cephalon (single-label images not shown), with expression
domains that form a sharp boundary in the mantle zone
near the cephalic flexure (arrows in Figs. 6A, 6B, and 6E).
This differs from our observed coexpression of PITX2 and
GABA in the e10.5 ventral mesencephalon and provides
evidence for regional specificity in PITX2 function.
At e12.5, the extent of GABA-IR throughout the neuro-
epithelium overlaps significantly with PITX2, both in the
diencephalon and the mesencephalon (Fig. 7). High-
resolution microscopy suggests that GABA and PITX2
colocalize in the mesencephalon or future superior collicu-
lus (Figs. 7A and 7B), zona incerta/retromammillary region
(Figs. 7A and 7D), and first rhombomere (Figs. 7A and 7E). A
group of GABA-expressing PITX2-IR cells are present in a
stream of neurons that spans the alar and basal plates of the
pretectum (short arrows, Fig. 7A). In the e12.5 zli, GABA-IR
is present in cells adjacent to PITX2-IR cells (long arrows in
Figs. 7A and 7C). In situ hybridization with probes specific
for Pitx2 and Gad1 on adjacent sections demonstrated that
Gad1 is not expressed in the zli (Fig. 8), confirming that
PITX2 is expressed in non-GABAergic neurons of the zli.
At e14.5, PITX2-IR and GABA-IR are further dispersed
throughout the mesencephalon and diencephalon relative to
e12.5 (see Figs. 9A and 9B, low-power views showing detailed
anatomy). High-resolution analysis at e14.5 suggests that
PITX2-positive cells in the future superior colliculus are
GABAergic, as are cells in the zona incerta/retromammillary
region (Figs. 9A and 9B). However, PITX2-positive cells of the
subthalamic nucleus, supramammillary nucleus, medial
mammillary nucleus, and posterior hypothalamic area do not
significantly colocalize with GABA (Figs. 9A and 9B), suggest-
ing that subthalamic and mammillary nuclei contain PITX2-
positive, non-GABAergic neurons. Our data are in agreement
with previous studies showing Pitx2 mRNA and absence of
GAD expression in subthalamic and mammillary nuclei (Ben-
son et al., 1991). We found that the distribution of PITX2
immunoreactivity is widely distributed throughout the mid-
brain and thalamus at e14.5, consistent with neuronal migra-
tion in these regions. The emergence of distinct PITX2-
positive anatomic regions, such as the subthalamic nucleus,
indicates that PITX2 may be necessary for migration and
coalescence of neurons destined to reside in these discrete
anatomic regions.
PITX2 and Neuronal or Glial Progenitors
Our results showing PITX2 expression in developing
TUJ1-positive and MAP2-positive neurons suggest that
PITX2 may be important for neurogenesis or specification
of the neuronal lineage in certain CNS regions. By e10.5,
most PITX2-positive cells of the mesencephalon occupy the
mantle zone and have lost their proliferative potential.
Similarly, in the e10.5 ventral diencephalon, PITX2 expres-
sion is highest in the differentiating zone, where TUJ1 and
MAP2 signal is concentrated. PITX2 signal throughout the
e10.5 CNS declines in a gradient toward the proliferative
ventricular zone. To address whether PITX2 is expressed in
undifferentiated progenitor cells, we performed double-
label studies at e10.5 with antibodies against the interme-
diate filaments nestin, vimentin, and glial fibrillary acidic
protein (GFAP).
We identified abundant nestin and vimentin immunore-
activity in the e10.5 neuroepithelium, and no detectable
GFAP, supporting previous reports of nestin and vimentin
expression in embryonic radial glia, some of which may
represent mitotically active neural progenitor cells (for
review, see Parnavelas and Nadarajah, 2001). In the e10.5
differentiating zone of the neuroepithelium, PITX2-positive
nuclei are organized in rows adjacent to nestin or vimentin-
labeled processes, indicating lack of colocalization (solid
arrows in Fig. 10). While faintly labeled PITX2-positive
nuclei residing near the ventricular zone appear to be in
close proximity to nestin or vimentin processes, there is no
convincing colocalization between PITX2 and nestin or
vimentin. By e12.5, nestin-IR is diminished relative to
e10.5, fewer PITX2-positive cells in the mesencephalic and
diencephalic neuroepithelium express nestin (data not
shown), and many more PITX2-positive cells express TUJ1
(Fig. 5). Our data are consistent with the hypothesis that
PITX2 expression is activated upon exit of cells from the
cell cycle and migration away from the ventricle toward the
pial surface. PITX2 expression may be coincident with
activation of the neuronal markers TUJ1 and MAP2 (com-
pare Figs. 4 and 10).
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DISCUSSION
Comparison with Earlier Work
Our results expand earlier Pitx2 mRNA expression data
and demonstrate PITX2-positive postmitotic neurons in the
developing CNS. In prior studies, two separate domains of
Pitx2 expression were proposed to exist at e11.5–e12.5
(Mucchielli et al., 1996). We detected PITX2-IR in a pattern
consistent with these domains. The first domain of Pitx2
mRNA expression occupies the region rostral to the zli,
FIG. 9. PITX2 and GABA immunoreactivity in the e14.5 CNS. The inset in (A) indicates the planes of two sections from an e14.5 embryo
labeled for PITX2 (TRITC, red nuclei) and GABA (FITC, green). Areas of colocalization between PITX2 and GABA include the
mesencephalon or future superior colliculus (SC), zona incerta/retromammillary region (zi/rmr). PITX2 nuclei in the supramammillary
nucleus (SMn), medial mammillary nucleus (MMn), subthalamic nucleus (Sth), and posterior hypothalamic region (pHthl) are negative for
GABA. Other abbreviations: Aq, cerebral aqueduct; cf, cephalic flexure. Scale bars are 200 m.
94 Martin et al.
© 2002 Elsevier Science (USA). All rights reserved.
includes basal plate expression in the hypothalamus (mam-
millary region, retromammillary region, zona incerta), and
extends to the zli. Within this domain, the region defined as
zona incerta may overlap with the retromammillary region,
based on Nkx6.1 (Puelles et al., 2001) and Dlx5 expression
data (Luis Puelles, personal communication).
The second Pitx2 expression domain is caudal to the zona
limitans and includes alar plate expression in the pretec-
tum, mesencephalon, and rhombomere one. In addition to
these two domains, we observed scattered PITX2-positive
cells that span the region between these two major expres-
sion domains (Figs. 3, 5, and 7). Differences in PITX2
expression between our study and previous reports may be
related to the sensitivity of methods used. With fluorescent
immunohistochemistry using PITX2 antisera and signal
amplification, we identify brightly labeled, individual
PITX2-positive nuclei that are not readily apparent by in
situ hybridization experiments (compare Fig. 1C with Fig.
2A). The presence of PITX2-labeled cells in the region
separating these two previously defined domains is signifi-
cant and suggests that PITX2-positive cells may have func-
tional relationships. Both the superior colliculus and zona
incerta/retromammillary region are sites of PITX2 expres-
sion and contain neurons involved in central visual process-
FIG. 10. PITX2 and intermediate filament expression in the e10.5
CNS. Triple-label for PITX2 (TRITC, red nuclei in A, B) and nestin
(C) or vimentin (D) (FITC, green cytoplasmic label) and nuclear
DAPI (E, F) in an e10.5 coronal section of the basal diencephalic
neuroepithelium. (G, H) Merged images of (A, C, E) and (B, D, F),
respectively. PITX label is faint in the ventricular zone (VZ) and
intense in some nuclei occupying the differentiating zone (DZ;
solid arrows in G, H). Scale bar is 10 m for each.
FIG. 11. Model for PITX2 function in the developing neuroepi-
thelium. As nestin- or vimentin-positive progenitors exit the cell
cycle and migrate toward the differentiating zone, PITX2 (red)
expression is activated and nestin/vimentin downregulated in a
subset of cells. Migrating PITX2-positive cells adopt a neuronal
fate, indicated by TUJ1 and MAP2 expression. A specific subset of
PITX2-positive neurons is GABAergic. Precise lineage and tempo-
ral relationships remain to be tested.
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ing (Power et al., 2001). Interestingly, PITX2-IR is promi-
nent in the developing eye (Hjalt et al., 2000), and loss of
Pitx2 disrupts both anterior and posterior ocular develop-
ment (Gage et al., 1999). These data provide incomplete but
intriguing evidence that Pitx2 may participate in the for-
mation of central visual pathways.
Zona Limitans Intrathalamica Is Comprised of
PITX2-Positive Neurons
We demonstrate PITX2 expression in GABA-negative,
postmitotic neurons in the e12.5 zli, and Gad1 mRNA in
cells immediately adjacent to the zli. In previous studies,
Gad1 expression was reported in the zli as early as e11.5,
but no definitive zli markers were used (Katarova et al.,
2000). In our studies, PITX2-positive nuclei are present in
neurons of the zli from e12.5 to e14.5 and extend from
ventricular to pial surfaces. Our observation of PITX2
expression in neurons of the zli differs from earlier notions
that neuromeric boundaries such as the zli are comprised
primarily of radial glia (Heyman et al., 1995). We speculate
that PITX2 may be involved in establishing the identity of
zli neurons or in maintaining zli function as a boundary
zone for cellular migration. Our data also provide evidence
against a role of PITX2 in patterning or establishment of
gene expression in the zli germinative epithelium. Experi-
ments in chick suggest that the zli may function as a
metameric compartment, rather than a boundary between
neuromeric compartments, based in part on the collapse of
Lunatic fringe (L-fng) expression (Larsen et al., 2001; Zeltser
et al., 2001). However, dynamic L-fng expression has not
been associated with altered cell death or proliferation,
raising the possibility that changes in gene expression
during CNS development may occur independent of
changes in cell number or fate. PITX2 is a candidate for
regulation of gene expression in the mature zli, through its
interactions with other transcription factors and signaling
molecules, such as Arx1, Dlx1, Dlx2, Fkh4, Lhx1, Lhx5,
Nkx2.2, Sim1, Sim2, and Wnt3a (Bachy et al., 2001; Fan et
al., 1996; Kaestner et al., 1996; Kitamura et al., 1997;
Mucchielli et al., 1996; Price et al., 1992; Spassky et al.,
1998).
To determine whether PITX2 is expressed in the glial
lineage, we tested for coexpression of PITX2 and GFAP or
O4, an antigenic marker present on oligodendrocyte precur-
sors (Bansal et al., 1992; Sommer and Schachner, 1981). At
e10.5, we detected absence of GFAP in PITX2-positive cells,
while e18.5 control optic nerve sections exhibited signifi-
cant GFAP label. At e12.5, we detected O4-positive cells in
the spinal cord but not in regions of PITX2 expression.
While PITX2 may be restricted to the neuronal lineage in
midgestation, absence of colocalization between PITX2 and
GFAP or O4 does not exclude the possibility that PITX2 is
expressed later in mature glia, since most gliogenesis occurs
in late embryonic and postnatal periods. Indeed, PITX2
shares common expression sites and may have a functional
relationship with sonic hedgehog (Shh) and the preoligoden-
drocyte markers proteolipid protein (plp) mRNA and its
alternatively spliced mRNA, dm-20. Both Shh and plp/
dm-20 are expressed at e12.5 in the dorsal mesencephalon,
ventral diencephalon, and zli, and are tightly linked to
oligodendrocyte formation (Nery et al., 2001; Perez Villegas
et al., 1999; Spassky et al., 1998).
A Role for PITX2 in Neuronal Differentiation
PITX2-positive nuclei occupy developing neurons, indi-
cated by coexpression with TUJ1 and MAP2. PITX2 expres-
sion in postmitotic neurons of the mesencephalon and
diencephalon suggests that PITX2 may be important for
establishment of neuronal identity, by influencing expres-
sion of genes involved in neuronal differentiation. There is
a striking difference between the mesencephalon and dien-
cephalon in the characteristics and locations of PITX2-
expressing cells. In the mesencephalon, PITX2-IR occupies
primarily the mantle zone, whereas in the diencephalon,
PITX2 forms a gradient of expression in the neuroepithe-
lium with highest expression in the differentiating zone.
The reasons for this difference in expression between the
diencephalon and mesencephalon may be related to the
timing of exit from the cell cycle or to differences in cellular
differentiation between these two regions. Of note, mesen-
cephalic neurons appear earlier in development than dien-
cephalic neurons, especially near the midline (Easter et al.,
1993), so PITX2 expression may reflect the onset of neuro-
nal differentiation. PITX2 may also have different roles in
the e10.5 mesencephalon and diencephalon that are re-
flected in their varied patterns of PITX2 expression.
We detected PITX2-IR and GABA-IR in a subset of
postmitotic ventral mesencephalic neurons as early as
e10.5. The mesencephalic domain of PITX2-IR in Gad1/
GABA-expressing neurons appears to correspond to the
proposed gap between dorsal and ventral Pitx2 mRNA
expression domains (Mucchielli et al., 1996). In the e10.5
ventral diencephalon, PITX2-IR cells occupy a region adja-
cent to GABA-IR cells, in contrast to PITX2 expression in
the e10.5 mesencephalon, where PITX2-IR and GABA-IR
are coexpressed in a discrete patch of neuroepithelium. At
e12.5, the expression pattern of GABA is much broader than
that of PITX2, and likely reflects the combined contribu-
tions of both GAD65 and GAD67, the two major forms of
GAD in the developing mouse brain (Katarova et al., 2000).
We propose a model for PITX2 function in early CNS
development (Fig. 11), wherein PITX2 expression is acti-
vated in a subset of neural progenitors as they exit from the
cell cycle, migrate away from the ventricular zone, and
differentiate into neurons. Some of these PITX2-positive
neurons become GABAergic, while others may adopt differ-
ent neurotransmitter phenotypes. Although our model pre-
dicts that Pitx2 expression precedes neuronal and GABAer-
gic differentiation, the exact temporal relationships have
not been explored. Some postmitotic, PITX2-positive cells
become neurons, but not all neurons express PITX2, sug-
gesting that PITX2 is not a neuronal lineage determinant.
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Instead, PITX2 appears to direct identity of a highly specific
subset of GABAergic and non-GABAergic neurons.
Our data provide evidence that Pitx2 is expressed in a
subset of developing GABAergic neurons, and should be
considered as a participant in neuronal differentiation. A
few mammalian transcription factors are expressed in asso-
ciation with specific neurotransmitter phenotypes, includ-
ing Pitx3 in dopaminergic mesencephalic neurons, Phox2 in
noradrenergic neurons, and Dlx1/2 in GABAergic telence-
phalic neurons (Anderson et al., 1997, 1999; Pattyn et al.,
2000; Smidt et al., 1997). Other transcription factors have
been identified in postmitotic cells, some of which consti-
tute anlagen of functional neurons, including Brn3.0 in
early postmitotic CNS cells (Fedtsova and Turner, 1995),
Otx1 in layers V and VI of cerebral cortex (Acampora et al.,
1999), and Isl-1 in differentiated motor neurons (Pfaff et al.,
1996). Some transcription factors are expressed in neural
progenitors and participate in terminal differentiation, in-
cluding Mash-1, essential for cell lineage determination in
olfactory and autonomic neurons (Guillemot et al., 1993;
Ma et al., 1997), and Gbx2, necessary for normal develop-
ment of thalamic cells that project to the cortex (Miyashita-
Lin et al., 1999).
Pitx2 deficiency in the pituitary results in hypoplasia and
abnormalities of hormone production, perhaps due to aber-
rant activation of hormone gene expression, Shh signaling,
or cell death (Suh et al., 2002). In the CNS, Pitx2 may be
necessary for specification of a subset of GABAergic neu-
rons, through regulation of transcription factor gene expres-
sion and direct effects on genes involved in neurotransmit-
ter synthesis. Pitx2 binds to the Dlx2 promoter and,
together with Msx2, represses Dlx2 transcription in tooth
epithelial cells (Green et al., 2001). Dlx2 and Pitx2 are both
expressed in zli and ventral thalamus (Bulfone et al., 1993),
and Dlx2 has been implicated in differentiation of GABAer-
gic neurons through direct activation of GAD (Stuhmer et
al., 2002), suggesting that Pitx2 and Dlx2 may have over-
lapping functions during development. It will be worth-
while to determine whether formation of PITX2-expressing
anatomic regions or GABAergic neuronal development is
disrupted with loss of Pitx2 function.
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